BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 18374689)

  • 1. Statins and cancer risk.
    Karp I; Behlouli H; Lelorier J; Pilote L
    Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and cancer risk: decrease or increase?
    Goldstein MR; Mascitelli L; Pezzetta F
    Am J Med; 2008 Sep; 121(9):e17, author reply e19. PubMed ID: 18724946
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between statins on clinical endpoints: a population-based cohort study.
    Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
    Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between time of statin initiation after hospital discharge from acute myocardial infarction and risk of recurrence and mortality in patients > or =65 years of age.
    Zhou Z; Rahme E; Pilote L
    Am J Cardiol; 2006 Jan; 97(2):155-9. PubMed ID: 16442354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins decrease the occurrence of venous thromboembolism in patients with cancer.
    Khemasuwan D; Divietro ML; Tangdhanakanond K; Pomerantz SC; Eiger G
    Am J Med; 2010 Jan; 123(1):60-5. PubMed ID: 20102993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of statin use in type 2 diabetics having macrovascular disease- at a Tertiary Care Hospital of Karachi.
    Basit A; Hydrie MZ; Hakeem R; Ahmedani MY; Masood Q
    J Ayub Med Coll Abbottabad; 2004; 16(4):60-4. PubMed ID: 15762067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early effects of statins in patients with coronary artery disease and high C-reactive protein.
    Muhlestein JB; Anderson JL; Horne BD; Carlquist JF; Bair TL; Bunch TJ; Pearson RR;
    Am J Cardiol; 2004 Nov; 94(9):1107-12. PubMed ID: 15518602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and the risk of 10 cancers.
    Coogan PF; Rosenberg L; Strom BL
    Epidemiology; 2007 Mar; 18(2):213-9. PubMed ID: 17235211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study.
    Daskalopoulou SS; Delaney JA; Filion KB; Brophy JM; Mayo NE; Suissa S
    Eur Heart J; 2008 Sep; 29(17):2083-91. PubMed ID: 18664465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.